Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 1 3Phase 4 2Phase 3 1Phase 1/2 1

Status

Completed 89Recruiting 11Unknown 9Not yet recruiting 5Active not recruiting 5Withdrawn 3Terminated 3Enrolling by invitation 2

Sponsor Class

OTHER 1226INDUSTRY 131OTHER_GOV 16NETWORK 15NIH 10INDIV 3FED 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Sarcopenia 1Rare Diseases 1Neurologic Manifestations 1Neoplasms 1Myasthenia Gravis 1Mental Disorders 1Breast Neoplasms 1

Interventions

Immunoglobulins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Terminated × FED × Clear all
NCT01954706 2015-11-26

BCS2

Baltimore VA Medical Center

Phase NA Terminated
5 enrolled
Breast

Breast Neoplasms, Sarcopenia

NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

FDA Office of Orphan Products Development

Phase NA Terminated
100 enrolled

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases

NCT00954148 2010-06-30

Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

Dallas VA Medical Center

Phase NA Terminated
53 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡